SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Drug Royalty Corporation (DRI-TSE) -- Ignore unavailable to you. Want to Upgrade?


To: philip trigiani who wrote (74)1/19/1999 8:06:00 AM
From: BioInv  Read Replies (1) | Respond to of 96
 
Do any of the institutional analysts follow DRI?. The EPS of 0.02 is a little disappointing given the high level of cash flow [0.07]... they seem to be writing off a lot of past investments. In spite of the good top line there is no growth in book from the annual report value a quarter earlier.